Citadel Advisors
UPH

Citadel Advisors’s UpHealth, Inc. UPH Stock Holding History

Citadel Advisors’s Portfolio UPH Stock Details UPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-8,416
Closed -$8.25K – 15747
2023
Q3 		$8.25K Buy
+8,416
New +$12.3K ﹤0.01% 13205
2023
Q1 		– Sell
-40
Closed -$65 – 16241
2022
Q4 		$65 Buy
+40
New +$156 ﹤0.01% 14778
2022
Q2 		– Sell
-3,021
Closed -$23.5K – 14699
2022
Q1 		$36K Sell
3,021
-13,089
-81% -$290K ﹤0.01% 13012
2021
Q4 		$361K Buy
16,110
+2,323
+17% +$53.8K ﹤0.01% 10497
2021
Q3 		$435K Buy
+13,787
New +$720K ﹤0.01% 10224
2021
Q2 		– Sell
-5,786
Closed -$544K – 14748
2021
Q1 		$580K Sell
5,786
-22,493
-80% -$2.33M ﹤0.01% 9361
2020
Q4 		$3.1M Buy
+28,279
New +$2.91M ﹤0.01% 4538

Other funds holding UPH

CM
Cohanzick Management Pleasantville, New York $231K AUM 3.17% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
HAG
HighPoint Advisor Group Downers Grove, Illinois $2.39B AUM 28.86% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
CI
CAZ Investments Houston, Texas $85.6M AUM 156.27% 1-Year Est. Return

Citadel Advisors's UPH Position: Q4 2023 in Review

Citadel Advisors sold out of UpHealth, Inc. (UPH) in Q4 2023, closing a stake of 8,416 shares — an estimated $8.25K sold.

Citadel Advisors first reported a position in UPH in Q4 2020 and held it in 7 quarters. The position peaked at $3.1M in Q4 2020. 5 funds tracked by Wall St. Rank hold UPH as of Q4 2023.

  • Citadel Advisors reported no remaining UpHealth, Inc. position as of Q4 2023 after selling out during the quarter.
  • Citadel Advisors sold 8,416 UpHealth, Inc. shares in Q4 2023, an estimated $8.25K.
  • Citadel Advisors first reported a position in UpHealth, Inc. in Q4 2020 and held it in 7 quarters.
  • Citadel Advisors's UpHealth, Inc. position peaked at $3.1M in Q4 2020.
  • 5 funds tracked by Wall St. Rank held UpHealth, Inc. as of Q4 2023.

Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.